5 Questions With Michelle Kinder, Ph.D., Director of Translational Sciences at Incyte

Published on :

I was attracted to Incyte for its immuno-oncology pipeline. When I first joined Incyte as a Scientific Director, Immuno-Oncology in U.S. Medical Affairs, I had the opportunity to support the growing pipeline, explore novel biology and enable our therapeutics into clinical practice.

Underrepresented founders of early-stage, tech-enabled companies competing for more than $150K in 2022 Startup302 funding contest

Published on :

Delaware’s second annual community-led Startup302 funding competition is accepting applications from underrepresented founders with early-stage, technology-enabled ventures through Feb. 20. Focusing on underrepresented founders with a goal of tackling funding inequities and strengthening the regional startup community, the contest is offering more than $150,000 in non-dilutive grant prizes to winners along with mentoring and valuable networking connections such as introductions to potential investors.

Analytical Biological Services Inc. To Grow Operations and Team in Delaware

Published on :

Delaware’s booming life sciences sector continues to expand with plans by Analytical Biological Services Inc. (ABS) to double its workforce over the next three years.

The internationally recognized bioscience services company is retrofitting 30,000 square feet of space in New Castle for its new office headquarters and lab space. The expansion, supported by two grants from the Delaware Strategic Fund, will allow the company to meet significant projected growth and add 36 new high-paying, full-time, skilled trade and professional-level positions – more than doubling its current workforce – to the state’s economy.